Why Getting a Diagnosis Takes So Long, and What Helps
The short answer: DMD is confirmed by genetic testing, not by "let's wait and watch." Walking late, falling often, struggling on stairs and enlarged calves, together with a CK dozens of…
What parents ask most “He walked late, he falls all the time, and his calves look unusually big. Is it calcium, is he just slow — or is it DMD? What should we actually test?” “His creatine kinase (CK) came back dozens of times higher than normal. What does that mean? Does he still need genetic testing, or does he have to have a muscle biopsy?” “The report says ‘deletion of exons 45–50.’ What does that mean? Am I a carrier? What about my daughter? And what about another baby?” “His liver enzymes are high and he has been treated for hepatitis for ages. Could that be a misdiagnosis?”
The short answer: DMD is confirmed by genetic testing, not by “let's wait and watch.” Walking late, falling often, struggling on stairs and enlarged calves, together with a CK dozens of times above normal — when that combination appears, the DMD gene should be tested straight away. Muscle damage starts in infancy. By age 5 there is already significant muscle loss that cannot be reversed. Steroids, gene therapy and trials all have age and function cut-offs, so a year lost to late diagnosis is not just a year. It is muscle that never comes back.
Why so many children are held up
The World Duchenne Organization's 2024 white paper put the global average age at diagnosis at 4–5 years. The average delay from first symptoms to diagnosis is 1.1–2.2 years. A family sees, on average, three specialists, and nearly a third see four or more. US Centers for Disease Control and Prevention (CDC) figures are more detailed still: about one year, on average, between a parent first noticing motor delay and the first assessment, and about 2.5 years to a confirmed diagnosis.
Stories from China are harder to hear. In interviews by Southern Metropolis Daily, one child who kept falling at age 2 was told he was “fine,” and was not diagnosed until he was 10. Another child's raised transaminases were treated as hepatitis for a long time — in DMD, those enzymes leak from damaged muscle, not from the liver. One mother's first thought on diagnosis was, “Did I not feed him well enough?” None of this is parents not trying. The disease is good at disguising itself early on: calcium deficiency, cerebral palsy, hepatitis, slow development — each one is more common than DMD, and each one can delay the answer.
The right order to do things
Test CK first. A CK dozens of times above normal is the cheapest, fastest alarm bell. A paediatrician or neurologist can order the blood test.
Then confirm it with DMD genetic testing. The international consensus is CK-MM first, then genetic sequencing. A muscle biopsy is no longer required to confirm the diagnosis. Read three things in the report: is it a deletion, a duplication or a point mutation; exactly which exons are involved; and — this decides what comes later — whether an exon-skipping drug or a trial is even possible.
Test the family for carrier status too. Whether the mother is a carrier, and whether a daughter is a carrier, matters for the daughter's own heart monitoring later, and for prenatal diagnosis in a future pregnancy. PPMD data hold one finding that is both sad and reassuring: where a family has more than one affected child, the younger brother is diagnosed on average two years earlier than the older one. Parents generally felt early diagnosis was a good thing, above all for “preparing for school,” “getting support services” and “avoiding repeated trips from doctor to doctor” — though the price is that the worry starts earlier too.
In China | Abroad
There is no nationwide newborn screening for DMD, so diagnosis mostly depends on someone noticing symptoms. In practice, a parent's own alertness is the first screen. There is another practical problem: some insurers have refused critical-illness payouts because “no muscle biopsy was done.” That is not reasonable, and a Beijing court has already ruled for a family on this point (see Article 4). A genetic test report is evidence of diagnosis. | On 16 December 2025, the US formally added DMD to the federal Recommended Uniform Screening Panel (RUSP) for newborns, though states usually take years to put it into practice. About 360 boys with DMD are born in the US each year. Without screening, parents often notice something is wrong at around age 2, yet diagnosis commonly waits until age 5. Taiwan has included DMD in newborn screening since 2021.
Do not wait if you see these signs If a child is still unsteady at 18 months, falls frequently, walks on tiptoe, has to push on his thighs with his hands to stand up from the floor (Gowers' sign), has unusually large calves, or has unexplained raised CK or transaminases — go straight to paediatric neurology or a neuromuscular clinic, say the words “please help me rule out DMD,” and ask for CK and genetic testing.
Sources for this article
PPMD Newborn Screening Action Center (US births, age at diagnosis, RUSP timing), checked directly: https://www.parentprojectmd.org/advocacy/newborn-screening-action-center/
World Duchenne Organization, 2024 white paper on newborn screening (average age at diagnosis and delays): https://worldduchenne.org/wp-content/uploads/white-paper-on-newborn-screening-for-duchenne-muscular-dystrophy-the-time-to-start-is-now-world-duchenne-organization.pdf
Chinese families' diagnosis experiences (First Affiliated Hospital of Sun Yat-sen University, reposting Southern Metropolis Daily interviews): https://www.fahsysu.org.cn/article/29677 ; Rare Disease Information Network patient story: http://www.raredisease.cn/Story/Info/24242 ; Tencent News: https://news.qq.com/rain/a/20260917A0D4N600
